coinfect
like
frequent
farm
report
well
establish
primari
infect
pathogen
viral
bacteri
may
enhanc
infecti
potenti
secondari
pathogen
porcin
respiratori
diseas
complex
prdc
multifactori
diseas
affect
fatten
pig
caus
coinfect
viral
andor
bacteri
pathogen
includ
porcin
reproduct
respiratori
syndrom
viru
prrsv
actinobacillu
pleuropneumonia
other
prdc
common
diseas
swine
industri
result
signific
econom
loss
character
sever
symptom
includ
respiratori
distress
fever
lethargi
stunt
growth
death
coinfect
often
studi
observ
clinic
symptom
model
anim
howev
basic
mechan
involv
pathogenpathogen
interact
often
overlook
vitro
investig
provid
insight
understand
coinfect
laboratori
recent
develop
model
studi
coinfect
pleuropneumonia
prrsv
use
sjpl
cell
prrsv
member
arterivirida
famili
nidoviral
order
envelop
singlestrand
posit
sens
rna
viru
genom
approxim
kb
length
contain
open
read
frame
orf
prrsv
infect
pig
trigger
sever
symptom
ie
fever
inappet
cyanosi
reproduct
disord
ie
abort
stillborn
piglet
mummifi
fetus
respiratori
disord
ie
cough
hyperpnea
dyspnea
furthermor
prrsv
import
pathogen
swine
product
caus
import
econom
loss
effect
antivir
drug
commerci
avail
actinobacillu
pleuropneumonia
app
caus
agent
porcin
pleuropneumonia
import
diseas
swine
industri
diseas
well
control
usa
canada
still
signific
problem
latin
america
asian
european
countri
actinobacillu
pleuropneumonia
gramneg
rodshap
bacteria
member
pasteurellacea
famili
bacterium
known
possess
mani
virul
factor
includ
lipopolysaccharid
capsular
polysaccharid
outer
membran
protein
involv
acquisit
essenti
nutrient
surfac
molecul
involv
adher
respiratori
tract
apx
toxin
recent
review
virul
factor
pleuropneumonia
see
chier
collabor
recent
report
pleuropneumonia
cultur
supernat
antivir
activ
prrsv
vitro
sjpl
infect
cell
porcin
alveolar
macrophag
antivir
activ
induc
pleuropneumonia
lipopolysaccharid
peptidoglycan
fragment
ie
ligand
ident
molecul
respons
antivir
activ
unknown
identif
could
provid
basi
develop
new
therapeut
drug
includ
prophylact
drug
suitabl
biopharmaceut
properti
prrsv
infect
note
experi
perform
cultur
supernat
haemophilu
parasui
strain
nagasaki
close
rel
pleuropneumonia
show
antivir
activ
prrsv
j
labri
jacqu
unpublish
data
hypothes
cultur
supernat
pleuropneumonia
induc
specif
sjpl
cell
respons
antivir
activ
prrsv
first
object
present
studi
identifi
mechan
behind
antivir
activ
display
pleuropneumonia
second
object
identifi
molecul
present
pleuropneumonia
cultur
supernat
respons
antivir
activ
prrsv
therefor
first
use
antibodi
microarray
identifi
cell
pathway
modul
pleuropneumonia
cultur
supernat
observ
modul
cell
cycl
regul
pathway
confirm
modul
cell
cycl
analysi
use
flow
cytometri
also
demonstr
abil
two
known
cell
cycl
inhibitor
inhibit
prrsv
final
mass
spectrometri
use
detect
identifi
two
molecul
present
cultur
supernat
pleuropneumonia
collabor
recent
demonstr
cultur
supernat
kda
ultrafiltr
antivir
activ
vitro
prrsv
therefor
protein
profil
sjpl
cell
infect
prrsv
moi
andor
treat
cultur
supernat
perform
use
kinex
antibodi
microarray
eight
hundr
fifti
four
cell
signal
protein
target
use
phosphositespecif
antibodi
panspecif
antibodi
panspecif
antibodi
target
phosphoryl
unphosphoryl
protein
form
protein
classifi
nine
group
accord
cellular
function
transcript
translat
factor
protein
implic
signal
transduct
pathway
protein
implic
hostpathogen
interact
immun
respons
protein
implic
stress
respons
protein
implic
cell
spread
cell
migrat
cell
surviv
cell
growth
cell
cycl
cell
prolifer
apoptosi
signal
pathway
cytoskeletonassoci
protein
protein
implic
cell
biosynthesi
metabol
protein
implic
biolog
process
unclassifi
protein
data
express
percent
chang
control
mockinfect
untreat
sjpl
cell
cfc
present
fig
addit
file
tabl
cultur
supernat
upregul
inhibitor
nuclear
factor
kappab
kinas
subunit
beta
receptorinteract
serinethreonineprotein
kinas
cell
treat
cultur
supernat
cell
cycl
regul
protein
mphase
induc
phosphatas
inact
form
cyclindepend
kinas
activ
form
modul
cultur
supernat
regardless
whether
infect
prrsv
also
prrsv
seem
upregul
mitogenactiv
protein
kinas
mapk
mitogen
activ
protein
kinas
erk
pathway
pathway
inde
serinethreonineprotein
kinas
araf
rafa
receptorassoci
kinas
cyclic
amprespons
elementbind
protein
differenti
modul
presenc
absenc
cultur
supernat
thu
prrsv
upregul
mapkerk
pathway
cultur
supernat
seem
decreas
prrsv
induc
upregul
mapkerk
pathway
overal
antibodi
microarray
data
suggest
pleuropneumonia
cultur
supernat
modul
sjpl
cell
cycl
microarray
antibodi
data
suggest
cultur
supernat
modul
sjpl
cell
cycl
decid
analyz
sjpl
cell
cycl
h
treatment
cultur
supernat
use
flow
cytometri
sjpl
cell
incub
dmem
use
normal
cell
cycl
obtain
mean
sjpl
cell
phase
sjpl
cell
dnasynthesi
phase
sphase
sjpl
cell
mitot
phase
fig
b
use
control
two
molecul
known
modul
cell
cycl
differ
phase
nocodazol
interfer
polymer
microtubul
block
treat
cell
induc
cell
death
apoptosi
aphidicolin
dnapolymeras
inhibitor
induc
cell
cycl
arrest
sphase
sjpl
cell
treat
nocodazol
aphidicolin
observ
differ
treat
untreat
cell
fig
nocodazol
treatment
sjpl
cell
number
increas
mean
addit
apoptot
peak
peak
seen
expect
fig
aphidicolin
treatment
proport
sjpl
cell
sphase
increas
mean
fig
follow
valid
cell
cycl
control
sjpl
cell
treat
cultur
supernat
signific
variat
sjpl
cell
cycl
proport
n
p
observ
averag
proport
sjpl
cell
stay
untreat
cell
howev
proport
sjpl
cell
sphase
significantli
n
p
decreas
increas
respect
fig
b
indic
pleuropneumonia
cultur
supernat
effect
sjpl
cell
cycl
collabor
report
antivir
effect
cultur
supernat
prrsv
observ
infect
cell
provid
supplement
insight
impact
cell
cycl
arrest
caus
pleuropneumonia
cultur
supernat
sjpl
infect
cell
prrsv
infect
treat
cell
cultur
supernat
analyz
cell
cycl
cell
cycl
untreat
uninfect
cell
similar
sjpl
cell
cycl
proport
cell
three
phase
sphase
fig
b
cell
treat
nocodazol
aphidicolin
increas
proport
cell
nocodazol
sphase
aphidicolin
observ
fig
contrast
sjpl
cell
cell
treat
cultur
supernat
differ
observ
treat
control
cell
fig
b
know
cultur
supernat
modul
sjpl
cell
cycl
treat
cell
kda
dmem
ultrafiltr
control
kda
cultur
supernat
ultrafiltr
know
kda
fraction
also
modul
sjpl
cell
cycl
kda
cultur
supernat
ultrafiltr
significantli
n
p
increas
number
cell
mean
fig
b
left
side
thu
kda
cultur
supernat
ultrafiltr
possess
antivir
activ
prrsv
also
modul
sjpl
cell
cycl
modul
cell
cycl
also
observ
cell
treat
cultur
supernat
fig
b
right
side
suggest
potenti
link
cell
cycl
arrest
antivir
activ
prrsv
sjpl
cell
previous
shown
use
protein
profil
cultur
supernat
upregul
implic
cell
cycl
regul
pathway
two
specif
cell
cycl
inhibitor
use
verifi
whether
cell
cycl
modul
induc
cultur
supernat
due
andor
first
use
dim
specif
activ
cell
cycl
inhibitor
serinethreonineprotein
kinas
inhibitor
lead
cell
cycl
arrest
use
select
inhibitor
cell
cycl
activ
polokinas
isoform
protein
implic
transit
pathway
activ
promot
transit
use
complex
dim
treatment
induc
sjpl
cell
cycl
modul
fig
sjpl
cell
modul
dim
fig
b
number
cell
sphase
significantli
n
p
decreas
mean
dim
treatment
respect
fig
c
proport
cell
significantli
n
p
increas
mean
dim
treatment
respect
previous
observ
pleuropneumonia
cultur
supernat
fig
order
confirm
cell
cycl
arrest
perform
cell
count
indic
cell
prolifer
cell
count
treatment
ratio
second
first
count
determin
ratio
compar
untreat
cell
ratio
dmem
kda
dmem
ultrafiltr
ratio
fig
previous
shown
nocodazol
aphidicolin
block
sjpl
cell
cycl
fig
upper
panel
decreas
sjpl
prolifer
fig
furthermor
cell
treat
cultur
supernat
dim
show
significantli
n
p
less
prolifer
cell
treat
dmem
effect
observ
cell
treat
kda
dmem
ultrafiltr
cell
treat
kda
cultur
supernat
ultrafiltr
fold
chang
n
p
data
indic
cultur
supernat
kda
cultur
supernat
ultrafiltr
significantli
decreas
sjpl
cell
prolifer
know
cultur
supernat
disrupt
sjpl
cell
cycl
decreas
sjpl
cell
prolifer
interest
see
whether
cell
cycl
inhibitor
dim
also
block
prrsv
infect
sjpl
cell
sjpl
cell
infect
prrsv
treat
cultur
supernat
antivir
activ
observ
fig
previous
report
collabor
sjpl
infect
cell
treat
dim
prrsv
detect
contrast
dim
solvent
control
fig
similar
observ
done
cell
treat
solvent
control
fig
absenc
prrsv
sjpl
infect
cell
treat
dim
suggest
antivir
effect
two
cell
cycl
inhibitor
prrsv
order
identifi
activ
molecul
present
cultur
supernat
mass
spectrometri
use
interestingli
mass
spectrometri
collisioninduc
dissoci
provid
comprehens
spectra
allow
structur
inform
deriv
assist
bioinformat
thu
mass
spectrometri
use
analyz
kda
cultur
supernat
ultrafiltr
detect
identifi
character
activ
molecul
kda
dmem
kda
cultur
supernat
ultrafiltr
fraction
use
simpl
saltingout
liquidliquid
extract
order
remov
undesir
inorgan
molecul
supernat
analyz
full
scan
posit
ion
mode
lcmsm
result
present
total
ion
current
chromatogram
tic
fig
kda
dmem
ultrafiltr
kda
cultur
supernat
ultrafiltr
compar
two
uniqu
peak
observ
kda
cultur
supernat
ultrafiltr
fig
black
arrow
full
scan
spectra
extract
ion
chromatogram
show
presenc
two
individu
peak
mass
charg
mz
fig
mz
fig
product
ion
spectra
two
peak
acquir
mz
four
ion
observ
mz
six
ion
observ
mz
mz
howev
use
silico
fragment
predictor
databas
search
eg
metlin
succeed
unequivoc
identifi
two
molecul
present
pleuropneumonia
cultur
supernat
order
improv
fraction
kda
cultur
supernat
ultrafiltr
test
molecul
activ
separ
suspect
activ
ingredi
use
thinlay
chromatographi
compar
result
standard
run
chromatogram
migrat
carri
use
chloroformmethanol
mixtur
read
use
uva
observ
distinct
spot
retent
factor
rf
present
kda
cultur
supernat
ultrafiltr
fig
interestingli
distinct
spot
also
present
kda
cultur
supernat
ultrafiltr
two
refer
strain
pleuropneumonia
serotyp
serotyp
fig
tlc
spot
rf
excis
molecul
extract
acetonitril
analyz
lcmsm
tic
extract
ion
chromatogram
xic
kda
cultur
supernat
ultrafiltr
tlc
spot
rf
possess
uniqu
peak
observ
mz
mz
fig
thu
peak
correspond
mz
correspond
addit
tlc
spot
present
pleuropneumonia
cultur
supernat
collabor
recent
report
vitro
antivir
activ
pleuropneumonia
cultur
supernat
prrsv
sjpl
infect
cell
porcin
alveolar
macrophag
object
studi
present
identifi
mechan
behind
antivir
activ
display
pleuropneumonia
identifi
activ
molecul
present
pleuropneumonia
cultur
supernat
sjpl
infect
cell
demonstr
prrsv
strongli
upregul
mitogenactiv
protein
kinas
mapk
erk
pathway
use
rafa
creb
result
agreement
lee
lee
demonstr
activ
prrsv
infect
han
collabor
highlight
prrsv
induc
degrad
crebbind
protein
cbp
contrast
treatment
cell
pleuropneumonia
cultur
supernat
decreas
upregul
induc
prrsv
demonstr
pleuropneumonia
cultur
supernat
decreas
mapkerk
pathway
upregul
induc
prrsv
observ
interest
partli
explain
antivir
activ
cultur
supernat
prrsv
investig
peptidoglycan
fragment
stimul
nucleotidebind
oligomer
domain
nod
pathway
follow
activ
recruit
nuclear
factor
kappa
light
polypeptid
gene
enhanc
bcell
inhibitor
alpha
lead
activ
protein
profil
indic
specif
activ
upregul
cultur
supernat
absenc
prrsv
absenc
activ
pleuropneumonia
cultur
supernat
alon
certainli
puzzl
collabor
demonstr
nod
pathway
induct
use
peptidoglycan
fragment
lead
antivir
effect
result
confirm
observ
auger
collabor
demonstr
differenti
express
pathway
sjpl
cell
h
infect
pleuropneumonia
serotyp
sjpl
cell
treat
pleuropneumonia
cultur
supernat
observ
weak
upregul
auger
collabor
implic
pleuropneumonia
lipopolysaccharid
pathway
activ
absenc
activ
cultur
supernat
explain
pleuropneumonia
lipopolysaccharid
remov
cultur
supernat
convers
prrsv
seem
abl
activ
pathway
sjpl
cell
alreadi
observ
alveolar
macrophag
apoptosi
import
cell
process
regul
caspas
protein
observ
pleuropneumonia
cultur
supernat
weakli
regul
apx
toxin
pleuropneumonia
known
induc
apoptosi
activ
cjun
ntermin
kinas
jnk
mapk
pathway
use
apx
mutant
prevent
induct
jnkmapk
pathway
result
suggest
pleuropneumonia
cultur
supernat
induc
apoptosi
observ
peak
correspond
apoptosi
cell
cycl
analysi
fig
result
agreement
auger
collabor
carri
western
blot
detect
activ
conclud
pleuropneumonia
induc
apoptosi
sjpl
cell
cell
prolifer
tightli
control
process
mani
cell
cycl
checkpoint
modul
provok
cell
cycl
arrest
checkpoint
activ
dna
damag
provid
opportun
stop
repair
damag
cell
best
knowledg
observ
cell
cycl
arrest
induc
pleuropneumonia
never
report
howev
aggregatibact
actinomycetemcomitan
formerli
actinobacillu
actinomycetemcomitan
abl
stop
growth
induc
cell
cycl
arrest
hela
cell
product
cytoleth
distend
toxin
cdt
regard
prrsv
sun
collabor
demonstr
abil
non
structur
protein
control
cell
cycl
induc
cell
cycl
arrest
sphase
demonstr
pleuropneumonia
cultur
supernat
abl
induc
cell
cycl
arrest
sjpl
cell
result
decreas
cell
prolifer
use
plk
inhibitor
confirm
protein
profil
result
dim
known
induc
cell
cycl
arrest
decreas
prolifer
sjpl
cell
cell
cycl
arrest
induc
pleuropneumonia
due
inhibit
investig
pathway
use
westernblot
analysi
regul
protein
also
studi
effect
cultur
supernat
cell
line
collabor
shown
cultur
supernat
pleuropneumonia
antivir
effect
cell
agreement
find
cell
cycl
observ
demonstr
differenti
effect
cultur
supernat
sjpl
cell
sjpl
cell
cultur
supernat
induc
cell
cycl
arrest
wherea
cultur
supernat
antivir
cell
cycl
effect
cell
similar
effect
observ
cell
prolifer
cell
cycl
arrest
induc
dim
differ
sjpl
cell
support
result
indic
cultur
supernat
inhibit
prrsv
sjpl
cell
induc
cell
cycl
arrest
use
tandem
mass
spectrometri
isol
identifi
two
uniqu
peak
mz
mz
kda
cultur
supernat
ultrafiltr
abl
separ
purifi
kda
cultur
supernat
ultrafiltr
use
tlc
plate
interestingli
recov
two
peak
tlc
spot
extract
unfortun
mass
spectrometri
fingerprint
lead
identif
molecul
correspond
two
peak
order
obtain
inform
definit
identifi
activ
molecul
refin
extract
protocol
obtain
higher
puriti
product
amount
compat
nuclei
nuclear
magnet
reson
nmr
demonstr
first
time
pleuropneumonia
disrupt
sjpl
cell
cycl
prevent
sjpl
cell
prolifer
also
demonstr
import
cell
cycl
prrsv
infect
furthermor
two
put
molecul
identifi
cultur
supernat
seem
like
molecul
respons
antivir
activ
pleuropneumonia
prrsv
investig
molecul
hope
lead
develop
new
antivir
drug
prrsv
cell
cultur
product
purchas
gibco
life
technolog
grand
island
ny
usa
sjpl
cell
line
cell
line
known
support
prrsv
replic
sjpl
cell
provid
rg
webster
st
jude
children
hospit
memphi
tn
usa
histor
defin
porcin
lung
cell
later
found
come
monkey
sjpl
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
vv
fetal
bovin
serum
fb
mm
lglutamin
mm
sodium
pyruv
vv
mem
nonessenti
amino
acid
neaa
solut
streptomycin
uml
penicillin
mgl
gentamicin
mgl
amphotericin
b
cell
line
subclon
african
green
monkey
kidney
cell
line
cell
grown
minimum
essenti
medium
mem
supplement
vv
fb
mm
lglutamin
mm
hepe
streptomycin
uml
penicillin
mgl
amphotericin
b
cell
cultur
infect
atmospher
actinobacillu
pleuropneumonia
nonhemolyt
noncytotox
kindli
provid
ruud
pam
seger
msd
anim
health
boxmeer
netherland
strain
mutant
serotyp
refer
strain
produc
nonact
apxi
apxii
toxin
bacteria
grown
brain
heart
infus
broth
bhi
oxoid
ltd
basingstok
hampshir
england
bhi
agar
oxoid
ltd
supplement
adenin
dinucleotid
sigmaaldrich
st
loui
mo
usa
respect
prrsv
north
american
refer
strain
iafklop
use
studi
strain
genotyp
ii
strain
actinobacillu
pleuropneumonia
cultur
supernat
prepar
recent
describ
collabor
briefli
overnight
cultur
dilut
fresh
bhi
broth
grown
cultur
dilut
dmem
medium
supplement
fb
mm
lglutamin
mm
sodium
pyruv
neaa
cfuml
incub
overnight
bacteri
cell
centrifug
g
min
supernat
harvest
pass
filter
sarstedt
inc
newton
nc
usa
filtersteril
supernat
ultrafiltr
kda
membran
merck
millipor
ltd
carrigtohil
cork
ireland
result
cultur
supernat
ultrafiltr
filtersteril
supernat
store
month
supplement
dmem
medium
also
ultrafiltr
kda
membran
use
control
sampl
prepar
perform
describ
auger
collabor
briefli
flask
sarstedt
inc
confluent
sjpl
cell
cell
infect
iafklop
prrsv
strain
h
multipl
infect
moi
treat
cultur
supernat
left
untreat
h
condit
known
block
prrsv
replic
cell
wash
twice
dulbecco
phosphatebuff
salin
dpb
life
technolog
lysi
buffer
ad
mm
mop
ph
sigmaaldrich
mm
egta
sigmaaldrich
mm
edta
fisher
scientif
fair
lawn
nj
usa
mm
sodium
fluorid
sigmaaldrich
mm
ph
sigmaaldrich
mm
sodium
pyrophosph
sigmaaldrich
mm
sodium
orthovanad
sigmaaldrich
vv
triton
sigmaaldrich
one
proteas
inhibitor
cocktail
tablet
complet
mini
edtafre
roch
diagnost
gmbh
mannheim
germani
ph
cell
remov
use
cell
scraper
nalg
nunc
intern
rochest
ny
usa
transfer
microcentrifug
tube
ice
sonic
perform
joul
use
ultrason
processor
coleparm
vernin
hill
il
usa
order
lyse
cell
sampl
ultracentrifug
g
min
sorval
rc
ultracentrifug
beckman
coulter
mississauga
canada
protein
concentr
determin
supernat
use
pierc
bca
protein
assay
kit
thermo
fisher
scientif
inc
rockford
il
usa
adjust
mgml
sampl
analyz
use
kinex
antibodi
microarray
kinexu
bioinformat
corpor
vancouv
bc
canada
kinex
antibodi
microarray
includ
antibodi
target
differ
cell
signal
pathway
includ
panspecif
antibodi
phosphositespecif
antibodi
includ
antibodi
protein
kinas
antibodi
protein
phosphatas
antibodi
stress
respons
protein
antibodi
protein
implic
transcript
other
data
express
chemiluminesc
signal
ratio
versu
untreat
cell
percentag
chang
control
cfc
calcul
protein
divid
treat
condit
zratio
control
zscore
x
describ
previous
cell
cycl
analysi
done
use
modifi
protocol
sazer
sherwood
briefli
sjpl
cell
cultur
overnight
flask
sarstedt
inc
dmem
cell
treat
h
atmospher
either
dmem
kda
dmem
ultrafiltr
undilut
cultur
supernat
kda
cultur
supernat
ultrafiltr
nocodazol
sigmaaldrich
aphidicolin
sigmaaldrich
dim
r
system
inc
minneapoli
mn
usa
hydrochlorid
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
cell
wash
twice
dpb
trypsin
min
trypsin
life
technolog
inhibit
use
complet
medium
cell
centrifug
g
min
cell
wash
one
time
dpb
fix
permeabil
use
vv
cold
ethanol
h
room
temperatur
follow
overnight
incub
cell
wash
twice
dpb
treat
h
mg
ribonucleasea
rnasea
sigmaaldrich
dpb
cell
final
stain
propidium
iodid
pi
mgml
sigmaaldrich
stain
cell
analyz
bd
fac
calibur
becton
dickinson
mississauga
canada
measur
fluoresc
emiss
nm
excit
nm
analysi
event
evalu
dna
content
determin
modfit
lt
veriti
softwar
hous
inc
topsham
usa
provid
histogram
evalu
cell
cycl
distribut
compar
cell
prolifer
cell
viabil
treatment
use
countess
autom
cell
counter
life
technolog
trypsin
step
cell
cycl
analysi
protocol
cell
wash
twice
dpb
centrifug
g
min
cell
resuspend
ml
dpb
cell
suspens
ad
trypan
blue
life
technolog
dilut
ad
countess
cell
count
chamber
slide
life
technolog
perform
cell
count
viabil
measur
data
automat
express
number
viabl
cell
per
ml
detect
prrsv
infect
cell
use
modifi
immunofluoresc
assay
protocol
provost
collabor
detect
prrsv
antigen
briefli
confluent
cell
cell
per
well
plate
corn
inc
corn
ny
usa
infect
prrsv
moi
h
treat
h
either
dmem
kda
dmem
ultrafiltr
undilut
cultur
supernat
kda
cultur
supernat
ultrafiltr
dim
vv
ethanol
dim
solvent
vv
solvent
follow
infect
andor
treatment
cell
wash
fix
min
room
temperatur
vv
methanol
fisher
scientif
vv
aceton
jt
baker
inc
phillipsburg
nj
usa
solut
cell
wash
three
time
use
phosphatebuff
salin
without
kcl
pb
nacl
sigmaaldrich
mm
fisher
scientif
mm
biopharm
inc
laval
qc
canada
incub
min
rabbit
monospecif
antisera
antiprrsv
n
protein
dilut
pb
cell
wash
three
time
pb
incub
min
antirabbit
antiserum
fitcconjug
life
technolog
dilut
pb
final
cell
wash
three
time
pb
visual
use
leica
dmi
invert
widefield
fluoresc
microscop
leica
microsystem
inc
richmond
hill
canada
pictur
acquir
use
dfc
digit
camera
leica
microsystem
inc
imag
analyz
use
leica
applic
suit
softwar
version
leica
microsystem
inc
order
elimin
salt
remov
inorgan
contamin
saltingout
liquidliquid
extract
perform
briefli
ml
ultrafiltr
sampl
kda
mix
vigor
min
g
nacl
sigmaaldrich
ml
acetonitril
fisher
scientif
organ
layer
kept
decant
analysi
thinlay
chromatographi
tlc
plate
use
analyz
sampl
prepar
tlc
plate
use
isol
molecul
interest
sampl
analysi
kda
ultrafiltr
appli
cm
cm
length
width
silica
gel
plate
sigmaaldrich
prepar
tlc
plate
ml
kda
ultrafiltr
appli
cm
cm
length
width
silica
gel
plate
sigmaaldrich
sampl
separ
mobil
phase
compos
vv
chloroform
bdh
inc
toronto
ontario
canada
vv
methanol
fisher
scientif
saturatedclos
glass
chamber
migrat
perform
ambient
temperatur
migrat
plate
airdri
min
observ
ultraviolet
uva
light
ultralum
inc
claremont
ca
area
correspond
spot
interest
scrape
silica
gel
plate
transfer
microcentrifug
tube
extract
silica
weigh
molecul
extract
acetonitril
ratio
wv
h
room
temperatur
sampl
centrifug
g
min
supernat
kept
liquid
chromatographi
tandem
mass
spectrometri
lcmsm
analysi
lcmsm
system
includ
thermo
surveyor
autosampl
thermo
surveyor
ms
pump
thermo
lcq
advantag
ion
trap
mass
spectromet
thermo
scientif
san
jose
ca
usa
data
acquir
analyz
xcalibur
thermo
scientif
sampl
analyz
lcmsm
full
scan
posit
ion
mode
briefli
sampl
inject
separ
achiev
gradient
mobil
phase
along
microbor
column
thermo
biobas
mm
thermo
scientif
particl
size
initi
mobil
phase
condit
consist
acetonitril
water
fortifi
vv
formic
acid
ratio
min
ratio
maintain
min
linear
gradient
appli
ratio
maintain
min
mobil
phase
composit
ratio
revert
initi
condit
column
allow
reequilibr
min
total
run
time
min
flow
rate
fix
mass
spectromet
coupl
lc
system
use
pneumat
assist
electrospray
ion
sourc
esi
sheath
nitrogen
ga
set
unit
esi
electrod
set
v
posit
mode
capillari
temperatur
set
capillari
voltag
v
instrument
oper
full
scan
ms
mode
mz
msm
data
collect
abund
peak
data
depend
acquisit
dda
mode
use
peak
intens
threshold
count
per
second
cp
kda
ultrafiltr
dmem
use
neg
control
spectra
compar
kda
ultrafiltr
pleuropneumonia
cultur
supernat
tlc
extract
molecul
cell
cycl
data
analys
arcsin
squar
root
asin
sqrt
x
transform
perform
statist
analysi
n
equal
eight
agostino
pearson
omnibu
normal
test
util
follow
oneway
analysi
varianc
anova
dunnett
posttest
pair
ttest
determin
signific
differ
exist
differ
cell
cycl
phase
cellcount
result
untreat
treat
cell
statist
analys
perform
use
graphpad
prism
graphpad
softwar
inc
san
diego
ca
usa
signific
differ
consid
p
